CUSIP: 33938A105
Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,116,042
-
Share change
-
-181,810
-
Total reported value
-
$695,002
-
Price per share
-
$0.33
-
Number of holders
-
20
-
Value change
-
-$123,230
-
Number of buys
-
8
-
Number of sells
-
10
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2019
-
Previous quarter:
Q3 2018
Recent filing periods for CUSIP 33938A105:
Institutional Holders of FLEX PHARMA INC - COM (FLKS) as of Q4 2018
As of 31 Dec 2018,
FLEX PHARMA INC - COM (FLKS) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,116,042 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, AMERIPRISE FINANCIAL INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Vanguard Group Inc, PANAGORA ASSET MANAGEMENT INC, CITADEL ADVISORS LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Advisor Group, Inc., and Virtu Financial LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.